Search
10/11/2025
Health Status and Use of Healthcare Services of Undocumented Migrant Sex Workers in Catalonia: A Descriptive Study Using Administrative Registries.
Dalmau-Bueno, Albert, Albert-Ballestar, Sergi, Mansilla, Rosa, Garcia-Altes, Anna. Health Status and Use of Healthcare Services of Undocumented Migrant Sex Workers in Catalonia: A Descriptive Study Using Administrative Registries.. International Journal of Environmental Research and Public Health. 2025; 22(11)DOI:10.3390/ijerph22111696. PMID:. IF:(Q/D).
10/11/2025
Estimating the prevalence of chronic insomnia in patients with non-cancer chronic pain: Study protocol of a multicenter cross-sectional study
Moreno, Vicente, Martin-Pardo, Carme, Medel, Javier, Monerris, Mar, Ferrándiz, Marta, Lorente, Luís, Server, Anna, Serrano, Ancor, Carnaval, Thiago, Montes, Antonio, Videla, Sebastián. Estimating the prevalence of chronic insomnia in patients with non-cancer chronic pain: Study protocol of a multicenter cross-sectional study. Medicine: Case Reports And Study Protocols. 2025; 6(6)DOI:10.1097/MD9.0000000000000386. PMID:. IF:(Q/D).
09/11/2025
Study protocol for developing the evaluation instrument of guideline adherence to GRADE approach (GRADE-Check)
Jin, YH, Yan, SY, Yao, XM, Dahm, P, Alonso-Coello, P, Brignardello-Petersen, R, Keitz, S, Rylance, J, Cheung, M, Agoritsas, T, Kunkle, R, Murad, MH, Guyatt, G. Study protocol for developing the evaluation instrument of guideline adherence to GRADE approach (GRADE-Check). BMJ Open. 2025; 15(11)DOI:10.1136/bmjopen-2025-105534. PMID:41213689. IF:2.300(Q2/3D).
08/11/2025
Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial
De Santis, M, Redorta, JP, Nishiyama, H, Krawczynski, M, Seyitkuliev, A, Novikov, A, Guerrero-Ramos, F, Zukov, R, Kato, M, Kawahara, T, Goeman, L, Puente, J, Hellmis, E, Powles, T, Radziszewski, P, Gust, KM, Vasey, P, Bigot, P, Fradet, Y, Hunting, J, Armstrong, J, Boulos, S, Hois, S, Shore, ND. Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial. LANCET. 2025; 406(10516)DOI:10.1016/S0140-6736(25)01897-5. PMID:41115436. IF:88.500(Q1/1D).
08/11/2025
Measuring the effect of rozanolixizumab using the Myasthenia Gravis Impairment Index: analyses from the randomized phase 3 MycarinG study
Barnett-Tapia, C, Vicente, EC, Pascuzzi, RM, Utsugisawa, K, Bloemers, J, Grimson, F, Tarancon, T, Bril, V. Measuring the effect of rozanolixizumab using the Myasthenia Gravis Impairment Index: analyses from the randomized phase 3 MycarinG study. JOURNAL OF NEUROLOGY. 2025; 272(12)DOI:10.1007/s00415-025-13480-8. PMID:41205003. IF:4.600(Q1/2D).
06/11/2025
Histopathological Response After Neoadjuvant Chemotherapy for High-Risk Soft-Tissue Sarcomas A Secondary Analysis of a Randomized Clinical Trial
Pasquali, S, Collini, P, Romagosa, C, Coindre, JM, Pizzamiglio, S, Verderio, P, Duroni, V, Barisella, M, Palmerini, E, Quagliuolo, V, Broto, JM, Pousa, AL, Grignani, G, Brunello, A, Blay, JY, Lugowska, I, Fontana, V, Bianchi, G, Palassini, E, Renne, SL, Casali, PG, Miceli, R, Sbaraglia, M, Gambarotti, M, Bagué, S, Dei Tos, AP, Stacchiotti, S, Gronchi, A. Histopathological Response After Neoadjuvant Chemotherapy for High-Risk Soft-Tissue Sarcomas A Secondary Analysis of a Randomized Clinical Trial. JAMA Network Open. 2025; 8(11)DOI:10.1001/jamanetworkopen.2025.40177. PMID:41196599. IF:9.700(Q1/1D).